BlackRock’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.19B Buy
72,643,002
+2,171,094
+3% +$193M 0.11% 158
2025
Q4
$5.57B Buy
70,471,908
+1,349,948
+2% +$106M 0.09% 167
2025
Q3
$5.53B Buy
69,121,960
+356,704
+0.5% +$30.4M 0.1% 162
2025
Q2
$6.25B Sell
68,765,256
-6,007,247
-8% -$548M 0.12% 147
2025
Q1
$7.01B Buy
74,772,503
+2,814,125
+4% +$252M 0.15% 119
2024
Q4
$6.54B Buy
71,958,378
+6,432,873
+10% +$614M 0.13% 125
2024
Q3
$6.8B Buy
65,525,505
+3,908,367
+6% +$398M 0.14% 116
2024
Q2
$5.98B Buy
61,617,138
+2,133,434
+4% +$197M 0.14% 119
2024
Q1
$5.36B Buy
59,483,704
+3,311,864
+6% +$281M 0.12% 138
2023
Q4
$4.48B Buy
56,171,840
+327,850
+0.6% +$24.7M 0.11% 150
2023
Q3
$3.97B Sell
55,843,990
-3,069,075
-5% -$229M 0.11% 146
2023
Q2
$4.54B Sell
58,913,065
-8,912,526
-13% -$690M 0.13% 130
2023
Q1
$5.1B Sell
67,825,591
-217,360
-0.3% -$16.2M 0.15% 117
2022
Q4
$5.36B Buy
68,042,951
+3,131,708
+5% +$235M 0.17% 109
2022
Q3
$4.56B Buy
64,911,243
+12,810
+0% +$1M 0.16% 113
2022
Q2
$5.2B Sell
64,898,433
-1,676,571
-3% -$131M 0.17% 105
2022
Q1
$5.05B Buy
66,575,004
+1,356,519
+2% +$107M 0.14% 128
2021
Q4
$5.57B Buy
65,218,485
+5,039,853
+8% +$394M 0.14% 124
2021
Q3
$4.55B Sell
60,178,632
-1,308,331
-2% -$104M 0.13% 132
2021
Q2
$5B Buy
61,486,963
+433,721
+0.7% +$35.5M 0.14% 125
2021
Q1
$4.81B Buy
61,053,242
+2,946,033
+5% +$231M 0.14% 124
2020
Q4
$4.97B Sell
58,107,209
-1,953,000
-3% -$161M 0.16% 110
2020
Q3
$4.63B Buy
60,060,209
+3,752,328
+7% +$286M 0.17% 104
2020
Q2
$4.13B Sell
56,307,881
-2,516,617
-4% -$179M 0.16% 111
2020
Q1
$3.9B Sell
58,824,498
-1,581,383
-3% -$112M 0.19% 100
2019
Q4
$4.16B Buy
60,405,881
+1,249,169
+2% +$85.2M 0.16% 117
2019
Q3
$4.35B Sell
59,156,712
-1,049,103
-2% -$76.1M 0.18% 101
2019
Q2
$4.31B Buy
60,205,815
+279,887
+0.5% +$19.9M 0.18% 98
2019
Q1
$4.11B Sell
59,925,928
-722,677
-1% -$46.7M 0.18% 99
2018
Q4
$3.61B Buy
60,648,605
+7,236,342
+14% +$453M 0.18% 99
2018
Q3
$3.58B Sell
53,412,263
-61,459
-0.1% -$4.09M 0.15% 122
2018
Q2
$3.47B Sell
53,473,722
-479,577
-0.9% -$31.4M 0.16% 116
2018
Q1
$3.87B Buy
53,953,299
+1,592,608
+3% +$115M 0.18% 98
2017
Q4
$3.95B Buy
52,360,691
+711,972
+1% +$52M 0.19% 93
2017
Q3
$3.76B Buy
51,648,719
+855,650
+2% +$61.7M 0.19% 92
2017
Q2
$3.77B Sell
50,793,069
-536,297
-1% -$39.8M 0.2% 91
2017
Q1
$3.76B Buy
51,329,366
+49,319,793
+2,454% +$3.45B 0.21% 87
2016
Q4
$132M Sell
2,009,573
-43,496
-2% -$2.98M 0.19% 115
2016
Q3
$152M Buy
2,053,069
+59,378
+3% +$4.39M 0.22% 89
2016
Q2
$146M Buy
1,993,691
+152,872
+8% +$10.9M 0.22% 95
2016
Q1
$130M Sell
1,840,819
-402,729
-18% -$26.8M 0.21% 97
2015
Q4
$149M Sell
2,243,548
-32,339
-1% -$2.15M 0.22% 96
2015
Q3
$144M Buy
2,275,887
+213,328
+10% +$13.9M 0.23% 92
2015
Q2
$135M Sell
2,062,559
-284,406
-12% -$19.3M 0.2% 110
2015
Q1
$163M Buy
2,346,965
+18,612
+0.8% +$1.29M 0.22% 95
2014
Q4
$161M Sell
2,328,353
-122,750
-5% -$8.29M 0.23% 90
2014
Q3
$160M Sell
2,451,103
-164,525
-6% -$10.9M 0.23% 95
2014
Q2
$178M Buy
2,615,628
+228,166
+10% +$15.3M 0.27% 86
2014
Q1
$155M Buy
2,387,462
+48,765
+2% +$3.07M 0.25% 82
2013
Q4
$153M Buy
2,338,697
+36,810
+2% +$2.36M 0.25% 80
2013
Q3
$137M Buy
2,301,887
+153,384
+7% +$9.09M 0.26% 80
2013
Q2
$123M Buy
+2,148,503
New +$128M 0.24% 82

Other funds holding CL

BlackRock's CL Position: Q1 2026 in Review

BlackRock increased its Colgate-Palmolive (CL) stake by 3.1% in Q1 2026, buying an estimated $193M and bringing the position to 72,643,002 shares worth $6.19B. The position accounts for 0.11% of the portfolio, ranked #158.

BlackRock first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.01B in Q1 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • BlackRock held 72,643,002 shares of Colgate-Palmolive worth $6.19B as of Q1 2026.
  • BlackRock bought 2,171,094 Colgate-Palmolive shares in Q1 2026, an estimated $193M.
  • Colgate-Palmolive made up 0.11% of BlackRock's portfolio in Q1 2026, its #158 holding.
  • BlackRock first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's Colgate-Palmolive position peaked at $7.01B in Q1 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.